Potential drug targets for preeclampsia patients identified
Tuesday, April 29, 2014 - 15:10
in Health & Medicine
Preeclampsia patients have an overabundance of molecules that send detrimental signals, researchers have found. They also documented poor health outcomes in babies born to moms with the syndrome. “Preeclampsia is a multifaceted complication found uniquely in the pregnant patient and one that has puzzled scientists for years,” says the leader of the study. It affects about 5 percent of expectant moms, usually in the second half of pregnancy.